Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model
Clicks: 197
ID: 266561
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
197 views
59 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #206 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Formalin inactivated SARS-CoV-2 vaccine given within 3 days of live SARS-CoV-2 exposure does not worsen disease phenotypes, and may even ameliorate infection wi
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (22 words).
Try re-searching for a better abstract.
| Reference Key |
canclinicalabsence
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Li, Can;Chen, Yan-Xia;Liu, Fei-Fei;Lee, Andrew Chak-Yiu;Zhao, Yan;Ye, Zhan-Hong;Cai, Jian-Piao;Chu, Hin;Zhang, Rui-Qi;Chan, Kwok-Hung;Chiu, Kelvin Hei-Yeung;Lung, David Christopher;Sridhar, Siddharth;Hung, Ivan Fan-Ngai;To, Kelvin Kai-Wang;Zhang, Anna Jin-Xia;Chan, Jasper Fuk-Woo;Yuen, Kwok-Yung; |
| Journal | clinical infectious diseases |
| Year | Year not found |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.